4.5 Article

Nischarin as a functional imidazoline (I1) receptor

期刊

FEBS LETTERS
卷 580, 期 13, 页码 3070-3074

出版社

WILEY
DOI: 10.1016/j.febslet.2006.04.058

关键词

I1-receptor; Nischarin; MAPK; rilmenidine

资金

  1. NIAAA NIH HHS [AA07839, R01 AA007839] Funding Source: Medline

向作者/读者索取更多资源

Gene matching shows that Nischarin is a mouse homologue of human imidazoline receptor antisera-selective (IRAS) protein, a viable candidate of the imidazoline (I-1) receptor. Nischarin and IRAS share the functions of enhancing cell survival, growth and migration. Bioinformatics modeling indicates that the IRAS and Nischarin may be transmembrane proteins and the convergence information raises the interesting possibility that Nischarin might serve as the I-1-receptor. To test this hypothesis, we developed antibodies against the Nischarin protein, and conducted signal transduction (functional) studies with the I-1-receptor agonist rilmenidine in the presence and absence of Nischarin antisense oligodeoxynucleotides (ODNs). NIH3T3 cells transfected with the Nischarin cDNA and incubated with the newly synthesized antibody expressed a 190 kD band. The antibody identified endogenous Nischarin in differentiated PC12 cells around 210 kD, which is consistent with reported findings in other cells of neuronal origin. The immunoflourescence findings showed the targeted protein to be associated with the cell membrane in PC12 cells. Nischarin ODNs abolished the expression of Nischarin in PC12 cells. Equally important, the Nischarin ODNs eliminated the production of MAPKp42,44, a recognized signal transduction product generated by I-1-receptor activation in differentiated PC12 cells. Together, the present findings suggest that Nischarin may serve as the functional I,receptor or at least share a common signaling pathway in the differentiated PC12 cells. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据